Article
Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
The American journal of pathology - 1 Jul 2013
Crende Olatz, Sabatino Marianna, Valcárcel María, Carrascal Teresa, Riestra Pia, López-Guerrero Jose A, Nagore Eduardo, Mandruzzato Susanna, Wang Ena, Marincola Francesco M, Vidal-Vanaclocha Fernando
Abstract excerpt
IL-18 is an immune-stimulating cytokine that promotes experimental melanoma metastasis via vascular endothelial growth factor (VEGF)-induced very late antigen (VLA)-4. We studied genes associated with the ability of melanoma cells to allow metastasis under IL-18 effects, and we verified their expression in metastatic lesions from patients with melanoma. Human melanoma cell lines with and without the IL-18...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
